首页> 外文期刊>Fish & Shellfish Immunology >Response of triploid Atlantic salmon (Salmo salar) to commercial vaccines
【24h】

Response of triploid Atlantic salmon (Salmo salar) to commercial vaccines

机译:三倍体大西洋三文鱼(沙摩酱)对商业疫苗的响应

获取原文
获取原文并翻译 | 示例
           

摘要

While triploid Atlantic salmon represent a practical and affordable solution to the issues associated with sexual maturation in the salmonid aquaculture industry, empirical evidence suggests triploids are more susceptible to disease and vaccine side-effects than diploids. With vaccination now part of routine husbandry, it is essential their response be studied to confirm their suitability for commercial production. This study tested the response of triploid and diploid Atlantic salmon to vaccination with commercially available vaccines. Triploid and diploid Atlantic salmon siblings were injected with one of three commercial vaccines (or sham-vaccinated) and monitored for performance throughout a commercial production cycle. Sampling at smolt and harvest was undertaken along with individual weight and length assessments through the cycle. Antibody response to Aeromonas salmonicida vaccination was similar in both ploidy, with a positive response in vaccine-injected fish. For both adhesions and melanin, analysis found that higher scores were more likely to occur as the anticipated severity of the vaccine increased. In addition, for adhesion scores at smolt and melanin scores at smolt and harvest, triploids were statistically more likely to exhibit high scores than diploids. Triploids maintained a significantly higher body weight during freshwater and until 11 months post-seawater transfer, with diploids weighing significantly more at harvest. Growth, represented by thermal growth coefficient (TGC), decreased in both ploidy as the severity of adhesions increased, and regression patterns did not differ significantly between ploidy. Vertebral deformity prevalence was consistently higher in triploids (smolt 12.3 +/- 4.5%; harvest 34.9 +/- 5.9%) than diploids (smolt 0.8 +/- 0.5%; harvest 15.9 +/- 1.9%), with no significant difference between vaccine groups in each ploidy. This study demonstrates that triploids respond as well to vaccination as diploids and provides further supporting evidence of triploid robustness for commercial aquaculture.
机译:虽然三倍体大西洋鲑鱼代表了与鲑鱼水产养殖业中性成熟相关的问题的实用且实惠的解决方案,但经验证据表明三倍体比二倍体更容易患疾病和疫苗副作用。患有疫苗接种现在是常规饲养的一部分,研究他们的回应是确认他们对商业生产的适合性。该研究测试了三倍体和二倍体大西洋鲑鱼与市售疫苗接种的响应。三倍体和二倍体大西米鲑鱼兄弟姐妹用三种商业疫苗(或假疫苗)中的一种注射,并在商业生产周期中监测性能。通过循环,采用SPOLT和Harvest的采样以及单独的重量和长度评估。对Aeromonas Salmonica接种疫苗接种的抗体反应在两个倍率中相似,具有疫苗注入的鱼中的阳性反应。对于粘连和黑色素,分析发现,随着疫苗的预期严重程度增加,更可能发生更高的分数。此外,对于Smolt和Hefly的Smolt和黑色素分数的粘附分数,三倍体更容易表现出高分性的差异。在淡水期间,三倍体保持较高的体重,直到海水转移后11个月,收获的多倍体更大。由热生长系数(TGC)表示的生长在倍增性随着粘连的严重程度增加,并且回归模式在倍增性之间没有显着差异。椎体畸形患病率在三倍体中始终较高(Smolt 12.3 +/- 4.5%;收获34.9 +/- 5.9%)比二倍体(Smolt 0.8 +/- 0.5%;收获15.9 +/- 1.9%),之间没有显着差异每倍倍增的疫苗组。本研究表明三倍体响应作为二倍体的疫苗接种,并进一步支持商业水产养殖的三倍体稳健性的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号